Cellectis S.A.

CLLS - CIK 0001627281

Market cap-

Rank-

SEC filings517

Cellectis S.A. trades as CLLS. This page tracks Cellectis S.A. through 517 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Total assets (latest FY)$324.72MFY 2025

Latest filings

Filing	Type	Filed
6-K	-	2026-05-21
6-K	-	2026-05-20
6-K	-	2026-05-12
6-K	-	2026-05-11
6-K	-	2026-05-11
6-K	-	2026-05-04
6-K	-	2026-04-27
6-K	-	2026-04-13

Browse the full filing history (517 filings)

Similar companies

The largest companies sharing Cellectis S.A.'s SEC industry classification (biological products, (no diagnostic substances)).

AMGNAmgen Inc.$191.09 B CLLS vs AMGN

GILDGilead Sciences, Inc.$156.28 B CLLS vs GILD

ARGXargenx SE$55.63 B CLLS vs ARGX

RVMDRevolution Medicines, Inc.$31.73 B CLLS vs RVMD

BIIBBiogen Inc.$29.52 B CLLS vs BIIB

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.